274 related articles for article (PubMed ID: 22013566)
1. Psychosis in Parkinson's disease: therapeutic options.
Hasnain M
Drugs Today (Barc); 2011 May; 47(5):353-67. PubMed ID: 22013566
[TBL] [Abstract][Full Text] [Related]
2. Treatment of psychosis in Parkinson's disease: safety considerations.
Fernandez HH; Trieschmann ME; Friedman JH
Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology and treatment of psychosis in Parkinson's disease: a review.
Zahodne LB; Fernandez HH
Drugs Aging; 2008; 25(8):665-82. PubMed ID: 18665659
[TBL] [Abstract][Full Text] [Related]
4. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
5. [Clozapine for the treatment of psychosis in 3 elderly patients with Parkinson's disease].
Diraoui S; van Melick EJ; Jansen PA
Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2365-8. PubMed ID: 15615268
[TBL] [Abstract][Full Text] [Related]
6. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
Drach LM
Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions for psychosis in Parkinson's disease patients.
Friedman JH
Expert Opin Pharmacother; 2018 Apr; 19(5):499-505. PubMed ID: 29494265
[TBL] [Abstract][Full Text] [Related]
8. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
[TBL] [Abstract][Full Text] [Related]
9. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
Friedman JH; Berman RM; Goetz CG; Factor SA; Ondo WG; Wojcieszek J; Carson WH; Marcus RN
Mov Disord; 2006 Dec; 21(12):2078-81. PubMed ID: 17013906
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotic drugs in the treatment of Parkinson's disease.
Friedman JH
J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576
[TBL] [Abstract][Full Text] [Related]
11. Clozapine and risperidone treatment of psychosis in Parkinson's disease.
Ellis T; Cudkowicz ME; Sexton PM; Growdon JH
J Neuropsychiatry Clin Neurosci; 2000; 12(3):364-9. PubMed ID: 10956570
[TBL] [Abstract][Full Text] [Related]
12. Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease.
Broadstock M; Ballard C; Corbett A
Expert Rev Clin Pharmacol; 2014 Nov; 7(6):779-86. PubMed ID: 25301532
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease.
Parsa MA; Bastani B
J Neuropsychiatry Clin Neurosci; 1998; 10(2):216-9. PubMed ID: 9608412
[TBL] [Abstract][Full Text] [Related]
14. Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis.
Frieling H; Hillemacher T; Ziegenbein M; Neundörfer B; Bleich S
Eur Neuropsychopharmacol; 2007 Feb; 17(3):165-71. PubMed ID: 17070675
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia.
Marsh L; Lyketsos C; Reich SG
Psychosomatics; 2001; 42(6):477-81. PubMed ID: 11815682
[TBL] [Abstract][Full Text] [Related]
16. The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease.
Divac N; Stojanović R; Savić Vujović K; Medić B; Damjanović A; Prostran M
Behav Neurol; 2016; 2016():4938154. PubMed ID: 27504054
[TBL] [Abstract][Full Text] [Related]
17. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
18. Treatment options for depression and psychosis in Parkinson's disease.
Poewe W; Seppi K
J Neurol; 2001 Sep; 248 Suppl 3():III12-21. PubMed ID: 11697683
[TBL] [Abstract][Full Text] [Related]
19. Current Understanding of Psychosis in Parkinson's Disease.
Ojo OO; Fernandez HH
Curr Psychiatry Rep; 2016 Oct; 18(10):97. PubMed ID: 27629356
[TBL] [Abstract][Full Text] [Related]
20. Clozapine for the treatment of psychosis in Parkinson's disease: chart review of 49 patients.
Wagner ML; Defilippi JL; Menza MA; Sage JI
J Neuropsychiatry Clin Neurosci; 1996; 8(3):276-80. PubMed ID: 8854298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
